4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-23-072866
CFO, EVP & Treasurer sold 36,868 shares at an average $50.85 ($1,874,790)
- CFO, EVP & Treasurer acquired 36,868 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PETERS WILLIAM J CFO, EVP & Treasurer | 2023-06-15 | Option exercise 10b5-1 | +36,868 | $19.79 | $729,618 | 142,471 | D |
| PETERS WILLIAM J CFO, EVP & Treasurer | 2023-06-15 | Sale 10b5-1 | −11,868 | $48.79 | $579,040 | 130,603 | D |
| PETERS WILLIAM J CFO, EVP & Treasurer | 2023-06-15 | Sale 10b5-1 | −12,000 | $50.79 | $609,480 | 118,603 | D |
| PETERS WILLIAM J CFO, EVP & Treasurer | 2023-06-15 | Sale 10b5-1 | −13,000 | $52.79 | $686,270 | 105,603 | D |
| Derivatives | |||||||
| PETERS WILLIAM J CFO, EVP & Treasurer | 2023-06-15 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −36,868 | 15,053 | D | ||
| Open-market sales · 36,868 sh · avg $50.85 · $1,874,790 | |||||||
Loading xslF345X04/tm2317726-14_4seq1.xml…